N-[9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide

Term ID

CHEBI:83097

Synonyms

N-[9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide

Definition

An aromatic amide obtained by formal condensation of the carboxy group of 3-(difluoromethyl)-1-methylpyrazole-4-carboxylic acid with the amino group of 9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-amine.

References

PPDB:2621

Ontology

ChEBI ( EBI )

Relationships

is a type of: aromatic amide bridged compound olefinic compound organochlorine compound organofluorine compound ... Show All 6 Terms

aromatic amide bridged compound olefinic compound organochlorine compound organofluorine compound pyrazoles Show first 5 Terms
has subtype: (1R,4S)-benzovindiflupyr (1S,4R)-benzovindiflupyr

(1R,4S)-benzovindiflupyr (1S,4R)-benzovindiflupyr Show first 5 Terms

Phenotype

Phenotype resulting from N-[9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide

Phenotype where environments contain N-[9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide

Phenotype modified by environments containing N-[9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide

Human Disease Model